Manglam Global Corporations Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Manglam Global Corporations Ltd is ₹ 16.23 as of 07 Jul 15:30 . The P/E Ratio of Manglam Global Corporations Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Manglam Global Corporations Ltd changed from ₹ 3.31 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The Revenue of Manglam Global Corporations Ltd is ₹ 2.69 crore as of Jun '25 .The Revenue of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Manglam Global Corporations Ltd is ₹ 0.02 crore as of Jun '25 .The EBITDA of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Manglam Global Corporations Ltd is ₹ 0.02 crore as of Jun '25 .The Net Profit of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Manglam Global Corporations Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Manglam Global Corporations Ltd

Manglam Global Corporations Limited was initially incorporated as 'Kshitij Investments Private Limited' on May 22, 1979.
The Company subsequently changed its name to Kshitij Investments Limited and obtained a fresh Certificate of Incorporation on December 03, 1979.
Currently, the name of the Company has changed to 'Manglam Global Corporations Limited' in 2024-25. Earlier, the Company was engaged in the business of trading in Iron & Steel and providing engineering services and other services for the Iron and Steel Industry.
As per changes set in the Memorandum of Association of the Company, the Company shifted its business toward agricultural commodities, food products and FMCG trading during the year 2024. Pursuant to change in Management there are few changes in the nature of business during the year 2024-25.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Manglam Global Corporations Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Manglam Global Corporations Ltd is 16 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Manglam Global Corporations Ltd stock price is INR ₹16.23. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Manglam Global Corporations Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.